Total Payments
$17,794
2024 Payments
$3,258
Companies
75
Transactions
1,020
Medicare Patients
6,008
Medicare Billing
$538,749
Payment Breakdown by Category
Food & Beverage$16,578 (93.2%)
Education$915.87 (5.1%)
Consulting$300.00 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,578 | 977 | 93.2% |
| Education | $915.87 | 41 | 5.1% |
| Consulting Fee | $300.00 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,781 | 121 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,072 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $977.71 | 60 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $905.55 | 72 | $0 (2024) |
| Amgen Inc. | $871.71 | 46 | $0 (2023) |
| Genentech USA, Inc. | $870.57 | 66 | $0 (2024) |
| PFIZER INC. | $847.46 | 46 | $0 (2024) |
| Janssen Biotech, Inc. | $709.53 | 39 | $0 (2024) |
| GENZYME CORPORATION | $600.92 | 28 | $0 (2024) |
| Incyte Corporation | $574.82 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,258 | 156 | PFIZER INC. ($447.68) |
| 2023 | $2,938 | 152 | Novartis Pharmaceuticals Corporation ($223.31) |
| 2022 | $2,839 | 158 | Novartis Pharmaceuticals Corporation ($315.41) |
| 2021 | $2,964 | 166 | Novartis Pharmaceuticals Corporation ($300.23) |
| 2020 | $1,650 | 102 | Amgen Inc. ($245.36) |
| 2019 | $1,552 | 108 | E.R. Squibb & Sons, L.L.C. ($221.66) |
| 2018 | $1,502 | 115 | Novartis Pharmaceuticals Corporation ($194.04) |
| 2017 | $1,091 | 63 | COMSORT, Inc ($300.00) |
All Payment Transactions
1,020 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Oncology | ||||||
| 12/16/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $31.27 | General |
| Category: Oncology | ||||||
| 12/13/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Oncology | ||||||
| 12/09/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.86 | General |
| 12/03/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: BioOncology | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi, Nubeqa | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Oncology | ||||||
| 11/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Neurology | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $27.08 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Oncology | ||||||
| 11/07/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Oncology | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Oncology | ||||||
| 11/01/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Oncology | ||||||
| 10/29/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,389 | 3,229 | $323,059 | $131,898 |
| 2022 | 10 | 1,533 | 3,375 | $318,328 | $132,467 |
| 2021 | 10 | 1,467 | 3,684 | $340,576 | $145,256 |
| 2020 | 12 | 1,619 | 3,959 | $345,867 | $129,128 |
Total Patients
6,008
Total Services
14,247
Medicare Billing
$538,749
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 455 | 1,039 | $190,011 | $90,078 | 47.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 74 | 74 | $25,079 | $11,444 | 45.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 355 | 1,016 | $45,720 | $7,666 | 16.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 352 | 888 | $21,312 | $7,402 | 34.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 57 | $19,437 | $7,277 | 37.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 25 | $6,012 | $3,272 | 54.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 26 | $5,434 | $1,918 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 40 | $4,870 | $1,792 | 36.8% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 20 | 64 | $5,184 | $1,049 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 434 | 991 | $169,461 | $85,577 | 50.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 75 | 75 | $24,975 | $12,038 | 48.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 128 | 140 | $15,960 | $8,528 | 53.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 384 | 1,096 | $49,320 | $8,299 | 16.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 48 | $16,368 | $7,178 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $8,384 | $3,174 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 23 | $5,382 | $3,156 | 58.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 387 | 908 | $21,792 | $2,663 | 12.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 13 | $2,717 | $1,025 | 37.7% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2022 | 13 | 49 | $3,969 | $829.27 | 20.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 426 | 1,074 | $183,927 | $96,845 | 52.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 66 | 66 | $21,978 | $10,501 | 47.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 363 | 1,159 | $52,155 | $8,967 | 17.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 119 | $13,566 | $7,130 | 52.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 41 | 46 | $15,686 | $6,908 | 44.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 41 | 41 | $10,742 | $4,911 | 45.7% |
About Dr. Abraham Cheong, M.D
Dr. Abraham Cheong, M.D is a Hematology & Oncology healthcare provider based in Brunswick, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285624882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abraham Cheong, M.D has received a total of $17,794 in payments from pharmaceutical and medical device companies, with $3,258 received in 2024. These payments were reported across 1,020 transactions from 75 companies. The most common payment nature is "Food and Beverage" ($16,578).
As a Medicare-enrolled provider, Cheong has provided services to 6,008 Medicare beneficiaries, totaling 14,247 services with total Medicare billing of $538,749. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Brunswick, GA
- Active Since 10/25/2005
- Last Updated 07/03/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1285624882
Products in Payments
- KEYTRUDA (Biological) $1,331
- OPDIVO (Biological) $458.67
- LIBTAYO (Biological) $451.17
- PROMACTA (Drug) $417.78
- KISQALI (Drug) $413.95
- Lenvima (Drug) $412.06
- MONJUVI (Drug) $353.08
- IMBRUVICA (Drug) $352.48
- INJECTAFER (Drug) $314.66
- CALQUENCE (Drug) $307.90
- ZEPZELCA (Drug) $300.67
- XTANDI (Drug) $290.34
- Stivarga (Drug) $280.37
- IMFINZI (Biological) $279.75
- GILOTRIF (Drug) $277.86
- Cabometyx (Drug) $268.95
- CABOMETYX (Drug) $256.36
- BOSULIF (Drug) $253.75
- MEKINIST (Drug) $252.54
- ADCETRIS (Biological) $245.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Brunswick
Edgardo Ortiz Flores, M.d, M.D
Hematology & Oncology — Payments: $4,718
Hematology & Oncology $4,718
Madelaine Sgroi, Do, DO
Hematology & Oncology — Payments: $3,531
Hematology & Oncology $3,531
Su-Chiao Kuo, Md, MD
Hematology & Oncology — Payments: $2,089
Hematology & Oncology $2,089
Dr. Duane Moores, M.d, M.D
Hematology & Oncology — Payments: $835.88
Hematology & Oncology $835.88
Hillary Glick, M.d, M.D
Hematology & Oncology — Payments: $215.16
Hematology & Oncology $215.16
Allison Smith, M.d, M.D
Hematology & Oncology — Payments: $214.98
Hematology & Oncology $214.98